Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-25-004069
Filing Date
2025-06-24
Accepted
2025-06-24 17:12:27
Documents
1
Period of Report
2025-06-20

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4388
  Complete submission text file 0001171843-25-004069.txt   6082
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Issuer) CIK: 0000898437 (see all company filings)

EIN.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address STRYKER 2825 AIRVIEW BLVD KALAMAZOO MI 49002
Business Address
Jellison William R (Reporting) CIK: 0001189883 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14027 | Film No.: 251070096